Search PubMed⌕ Search

Biomedical subjects

M Poullis

Publications and source records attributed to M Poullis.

At least 37 records · Page 2Linked to original sources
PubMed1999

Forearm fasciotomy post cardiac surgery.

Compartment syndrome is an uncommon diagnosis in the field of cardiac surgery. Early diagnosis and prompt operative decompression are essential for a successful outcome in terms of functional status of the limb concerned and mortality. The management of a compartment syndrome of the forearm is identical to that of the leg.

Aortic Valve↗
PubMed1999

Mannitol and cardiac surgery.

Mannitol is widely used in all fields of medicine, due to its beneficial actions on the kidney and brain. Mannitol has been extensively used in cardiac surgery since its infancy, and remains in common usage to day. Mannitol is mainly used for its effects on the kidneys, but it has actions on the brain, lungs, heart, gastrointestinal tract and the red cell. Mannitol also has effects on free radicals and nitric oxide. As with virtually all treatments in medicine and surgery its use is not immune from side effects. The medical literature on mannitol over the past 30 years is considered.

Adult↗
PubMed1999

Thoracic hernia.

Explore the source record for details and available documents.

Aged↗
PubMed1999

A quick simple method of determining platelet aggregability following glycoprotein IIb/IIIa receptor inhibitor administration.

Platelet aggregation assessment after therapeutic administration of a GP IIb/IIIa inhibitor has been difficult in routine practice due to the inherent nature of platelet preparation and aggregometry. Platelet microaggregation was performed via the utilisation of a Coulter counter. Citrate and heparin were evaluated as the anticoagulants, and ADP and adrenaline were evaluated as the stimulants. Aprotinin was also assessed. ReoPro was utilised in all assays as the GP IIb/IIIa inhibitor. Platelet microaggregation using the described methodology provides a quick, simple, reliable, and clinically valid method of assessing the percentage platelet inhibition due to the presence of a GP IIb/IIIa inhibitor.

Abciximab↗